State Street Extends OTC Clearing to CME

chicago-mercantile-exchange-cme
State Street has taken membership of the CME as a clearer, ahead of Title VII reforms in the Dodd-Frank Act.

The research and trading arm of State Street is joining ahead of incoming regulatory reform over the trading of standardized OTC derivatives contracts. Under the new rules, part of the US Dodd-Frank Act, trades must be performed through Swap Execution Facilities and cleared through qualified entities.

"As derivative markets evolve, State Street's membership provides buy-side clients with a new, neutral model for trading, clearing and processing of their swap positions," says Cliff Lewis, executive vice president and head of State Street's eExchange business. "Joining CME Group, one of the world's leading derivatives marketplaces, is an important step towards offering a fully comprehensive, end-to-end derivatives solution for our clients."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

If M&A picks up, who’s on the auction block?

Waters Wrap: With projections that mergers and acquisitions are geared to pick back up in 2025, Anthony reads the tea leaves of 25 of this year’s deals to predict which vendors might be most valuable.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here